Javed Khan, M.D.

Javed  Khan, M.D.
Deputy Chief
Senior Investigator
Head, Oncogenomics Section

The mission of the Oncogenomics Section is to harness the power of high throughput genomic and proteomic methods to improve the outcome of children with high-risk metastatic, refractory and recurrent cancers. The research goals are to integrate the data, decipher the biology of these cancers and to identify and validate biomarkers and novel therapeutic targets and to rapidly translate our findings to the clinic.

Areas of Expertise
1) oncogenomics, 2) genomics, 3) proteomics, 4) immunogenomics

Contact Info

Javed Khan, M.D.
Center for Cancer Research
National Cancer Institute
Building 37, Room 2016B
Bethesda, MD 20892
Ph: 240-760-6135
khanjav@mail.nih.gov

Mission of the Oncogenomics Section

The mission of the Oncogenomics Section is to harness the power of high throughput genomic and proteomic methods to improve the outcome of children with high-risk metastatic, refractory and recurrent cancers. The research goals are to integrate the data, decipher the biology of these cancers and to identify and validate biomarkers and novel therapeutic targets and to rapidly translate our findings to the clinic. For more information about our research, visit the Oncogenomics Section website.

1. Comprehensive Omics Analysis: a) Applying high-throughput genomics, proteomics mathematical modeling and bioinformatics to characterize currently incurable malignancies including metastatic, resistant and relapsed tumors for the identification and validation of biomarkers and therapeutic targets. b) Genome wide association studies and mutational screening of germ-line DNA.

2. Targeted Therapeutics: a) High-throughput siRNA, small molecule, natural products, and drug screening for high-risk pediatric malignancies. b) Development of molecularly targeted therapeutic agents against existing and newly identified targets.

3. Translational Oncology: Leverage the existing clinical and scientific strengths within the Genetics Branch including phase 1/2 therapeutics, immune/vaccine therapy and molecular biology to translate these findings to the clinic in an environment where there is state-of-the-art clinical care.

Scientific Focus Areas:
Cell Biology, Computational Biology, Genetics and Genomics, Molecular Biology and Biochemistry, Systems Biology
  1. Gryder BE, Yohe ME, Chou H-C, Zhang X, Marques J, Wachtel M, Schaefer B, Sen N, Song Y, Gualtieri A, Pomella S, Rota R, Cleveland A, Wen X, Sindiri S, Wei JS, Barr FG, Das S, Andresson T, Guha R, Lal-Nag M, Ferrer M, Shern JF, Zhao K, Thomas CJ, Khan J.
    Cancer Discov. 7(8): 884-899, 2017. [ Journal Article ]
  2. Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J.
    Clin Cancer Res. 22(15): 810-20, 2016. [ Journal Article ]
  3. Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG, Hawkins DS, Khan J.
    PLoS Genet . 11: e1005075 , 2015. [ Journal Article ]
  4. Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF, Liao H, Wen X, Gerard J, Kim JS, Lopez Guerrero JA, Machado I, Wai DH, Picci P, Triche T, Horvai AE, Miettinen M, Wei JS, Catchpool D, Llombart-Bosch A, Waldman T, Khan J.
    PLoS Genet. 10: e1004475, 2014. [ Journal Article ]
  5. Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, Ambrogio L, Auclair D, Wang J, Song YK, Tolman C, Hurd L, Liao H, Zhang S, Bogen D, Brohl AS, Sindiri S, Catchpoole D, Badgett T, Getz G, Mora J, Anderson JR, Skapek SX, Barr FG, Meyerson M, Hawkins DS, Khan J.
    Cancer Discov. 4: 216-31, 2014. [ Journal Article ]

Dr. Khan obtained his bachelor's degree in 1984 and his master's degrees in 1989 in immunology and parasitology at England's University of Cambridge. He subsequently obtained his M.D. there and the postgraduate degree of MRCP (Membership of the Royal College of Physicians), equivalent to board certification in the United States. After clinical training in internal medicine and pediatrics as well as other specialties, he received a Leukemia Research Fellowship. In May 2001, Dr. Khan joined the Pediatric Branch, NCI, as a tenure track investigator. Dr. Khan and colleagues have published a new model for diagnosis of cancer using artificial neural networks (ANN), a form of artificial intelligence, and microarray technology. In April 2001, Dr. Khan was recognized by the American Association for Cancer Research for his work in tumor profiling by receiving a Scholar in Training Award. Recently Dr Khan has led an international collaboration to perform comprehensive analysis of pediatric cancer genomes using next generation sequencing strategies.

Position Number of Positions Contact E-mail Contact Name Contact Phone
Postdoctoral Fellow 1 khanjav@mail.nih.gov Javed Khan
Name Position
Peter Azorsa Postbaccalaureate Fellow
Leslie Brents M.S. Biologist
Andrew Brohl M.D. Guest Researcher
Hsien-Chao Chou Bioinformatics Analyst (Leidos)
Scott A. Goldweber Bioinformatics Analyst (Leidos)
Berkley Gryder Ph.D. Postdoctoral Fellow (CRTA)
Igor Kuznetsov Ph.D. Research Collaborator
Rajesh Patidar M.S. Bioinformatics Scientist (Leidos)
Nityashree Shivaprasad M.S. Predoctoral Fellow
Sivasish Sindiri M.S. Bioinformatics Analyst (Leidos)
Young Song Ph.D. Biologist
Manoj Tyagi Ph.D. Bioinformatics Analyst (Leidos)
Jun S. Wei, Ph.D. Staff Scientist
Xinyu Wen M.S. Bioinformatics Analyst (Leidos)

Data Analysis Tools

Data Sets

Online Databases

Please note all of our databases have been consolidated into one.

Protocols